From Gred.ai Flashcards
1
Q
Liso-cel
A
JCAR 017
Large B-cell lymphoma (LBCL)
PFS: 12.6month (3rs rate = 50.9%) vs 6.2 month SOC (3yr = 26.5% SOC)
OS was 62.8% vs 51.8% SOC
2
Q
Yescarta (Axi-cel)
A
Relapsed/refractory large B-cell Lymphoma (LBCL)
ZUMA-1: median PFS = 5.9 months vs ~3 month SOC chemo
OS = 12 months
3
Q
Kymriah (Tisa-Cel)
A
Relapsed/refractory large B-cell Lymphoma (LBCL)
JULIET: PFS was ~3months, some up to 12months. OS 12-month = 52%
+ Pediatric Acute lymphocytic leukemia (ALL)
4
Q
A
5
Q
Abecma (idecabtagene vicleucel)
A
Muliple myeloma
KarMMa trial PFS = 8.8 months. SOC = 7.1 months, OS = 28 months
OS still being updated
6
Q
A